Table 1.
Sample characteristics of patients at baseline.
| Control (n = 177) | Intervention (n = 175) | df | p | |
|---|---|---|---|---|
| Age (SD)a | 86.5 (6.7) | 84.9 (7.0) | 350 | 0.022 |
| Women (%)b | 131 (74.0) | 131 (74.9) | 1 | 0.856 |
| FAST (SD)c | 6.0 (0.7) | 6.1 (0.7) | 349 | 0.057 |
| MMSE (SD)c | 8.4 (6.7) | 7.5 (6.5) | 346 | 0.177 |
| Barthels ADL total score (SD)c | 8.6 (5.6) | 7.9 (5.7) | 339 | 0.216 |
| CMAI total score (SD)c | 56.2 (16.1) | 56.5 (15.2) | 349 | 0.487 |
| MOBID-2 (SD)c | 3.7 (2.5) | 3.8 (2.7) | 325 | 0.988 |
| Medications (SD)c | 3.6 (1.6) | 3.4 (2.1) | 318 | 0.146 |
| Analgesics (%)b | 122 (68.9) | 117 (66.9) | 1 | 0.404 |
| Paracetamol (%)b | 94 (53.1) | 99 (56.6) | 1 | 0.665 |
| Opioids (%)b | 51 (28.8) | 43 (24.6) | 1 | 0.292 |
| NSAIDS (%)b | 9 (5.1) | 13 (7.4) | 1 | 0.364 |
| Psycholeptics (%)b | 112 (63.3) | 104 (59.4) | 1 | 0.458 |
| Antipsychotics (%)b | 13 (7.3) | 17 (9.7) | 1 | 0.465 |
| Anxiolytics (%)b | 86 (48.6) | 80 (45.7) | 1 | 0.589 |
| Psychosis symptoms (%)b | 71 (20.2) | 83 (23.6) | 1 | 0.209 |
| Delusion (%)b | 49 (27.7) | 66 (37.7) | 1 | 0.056 |
| Hallucination (%)b | 29 (16.4) | 32 (18.3) | 1 | 0.690 |
| Euphoria (%)b | 15 (8.5) | 16 (9.1) | 1 | 0.864 |
| Agitation symptoms (%)b | 128 (36.4) | 137 (38.9) | 1 | 0.285 |
| Agitation/aggression (%)b | 74 (41.8) | 85 (48.6) | 1 | 0.253 |
| Disinhibition (%)b | 56 (31.6) | 59 (33.7) | 1 | 0.760 |
| Irritability (%)b | 84 (47.5) | 85 (48.6) | 1 | 0.956 |
| Aberrant motor behaviour (%)b | 57 (32.2) | 65 (37.1) | 1 | 0.388 |
aIndependent-samples t-test.
bPearson's Chi-squared test.
cMann-Whitney U test.